Detection of Helicobacter pylori and Determination of Clarithromycin Susceptibility Using Formalin-Fixed, Paraffin-Embedded Gastric Biopsy Specimens by Fluorescence In Situ Hybridization
Background: Clarithromycin resistance and poor compliance to therapy are often responsible for Helicobacter pylori eradication therapy failure. Aim: To evaluate fluorescence in situ hybridization (FISH) as a nonculture method to simultaneously detect H. pylori and to identify clarithromycin resist...
Saved in:
Published in | Helicobacter (Cambridge, Mass.) Vol. 12; no. 2; pp. 136 - 141 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.04.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 1083-4389 1523-5378 |
DOI | 10.1111/j.1523-5378.2007.00483.x |
Cover
Summary: | Background: Clarithromycin resistance and poor compliance to therapy are often responsible for Helicobacter pylori eradication therapy failure.
Aim: To evaluate fluorescence in situ hybridization (FISH) as a nonculture method to simultaneously detect H. pylori and to identify clarithromycin resistance.
Methods: Fifty‐four patients with dyspepsia (17 male, 37 female subjects; mean age, 46.5; range, 21–78 years) were studied. Two antrum and corpus biopsies were taken from each patient. Positive rapid urease test (RUT) and histopathologic examinations defined H. pylori positivity. A total of 108 formalin‐fixed paraffin‐embedded gastric mucosal biopsies were examined retrospectively by the FISH (seaFAST H. pylori Combi‐Kit) method.
Results: Forty‐five patients (83.3%) were H. pylori positive and 43 (95.5%) were also positive by FISH. There were two false‐positive FISH results. Fourteen patients (31.1%) had clarithromycin‐susceptible strains, 4 (8.9%) resistant strains, and 27 (60%) both susceptible and resistant strains.
Conclusion: FISH results correlated well with H. pylori infection and were able to identify clarithromycin‐susceptible and ‐resistant strains. This technique will be helpful in determining the bacterial density and the success of treatment where clarithromycin has been widely used in populations to increase the efficacy of the treatment and to clarify the treatment failure in vitro. |
---|---|
Bibliography: | istex:A6F35408AD8A7D318EB5571DFE1AE6E91FDD1F2E ArticleID:HEL483 ark:/67375/WNG-GZP7SNHH-4 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 |
ISSN: | 1083-4389 1523-5378 |
DOI: | 10.1111/j.1523-5378.2007.00483.x |